0000899243-23-006468.txt : 20230228
0000899243-23-006468.hdr.sgml : 20230228
20230228185645
ACCESSION NUMBER: 0000899243-23-006468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230225
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bachleda Mark
CENTRAL INDEX KEY: 0001887762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 23688600
MAIL ADDRESS:
STREET 1: C/O GALERA THERAPEUTICS, INC.
STREET 2: 2 W LIBERTY BOULEVARD, #110
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-25
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001887762
Bachleda Mark
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
1.78
2023-02-25
4
A
0
135000
0.00
A
2033-02-24
Common Stock
135000
135000
D
The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.
/s/ Chris Degnan, Attorney-in-Fact for Mark J. Bachleda
2023-02-28